A.J. Cross

11.7k total citations
197 papers, 8.6k citations indexed

About

A.J. Cross is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Physiology. According to data from OpenAlex, A.J. Cross has authored 197 papers receiving a total of 8.6k indexed citations (citations by other indexed papers that have themselves been cited), including 119 papers in Cellular and Molecular Neuroscience, 78 papers in Molecular Biology and 26 papers in Physiology. Recurrent topics in A.J. Cross's work include Neuroscience and Neuropharmacology Research (86 papers), Neurotransmitter Receptor Influence on Behavior (37 papers) and Receptor Mechanisms and Signaling (35 papers). A.J. Cross is often cited by papers focused on Neuroscience and Neuropharmacology Research (86 papers), Neurotransmitter Receptor Influence on Behavior (37 papers) and Receptor Mechanisms and Signaling (35 papers). A.J. Cross collaborates with scholars based in United Kingdom, United States and Sweden. A.J. Cross's co-authors include Timothy J. Crow, F. Owen, John L. Waddington, P. Slater, Julie A. Johnson, Elaine K. Perry, Mark Poulter, A. Longden, Guy M. Goodwin and B.E. Tomlinson and has published in prestigious journals such as Nature, Science and The Lancet.

In The Last Decade

A.J. Cross

197 papers receiving 8.1k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
A.J. Cross 4.8k 3.1k 1.3k 1.2k 1.2k 197 8.6k
C. Anthony Altar 7.8k 1.6× 3.6k 1.2× 1.3k 1.0× 1.2k 0.9× 1.7k 1.4× 116 12.5k
Anat Biegon 3.5k 0.7× 2.2k 0.7× 1.1k 0.9× 745 0.6× 806 0.7× 187 8.4k
Stephen L. Dewey 5.7k 1.2× 2.5k 0.8× 1.1k 0.9× 620 0.5× 1.5k 1.2× 149 9.3k
Hayden T. Ravert 4.3k 0.9× 2.9k 1.0× 1.2k 0.9× 919 0.7× 1.5k 1.2× 195 9.8k
Paul L. Wood 5.0k 1.0× 4.5k 1.5× 747 0.6× 2.0k 1.6× 677 0.5× 271 9.6k
Sven Ove Ögren 8.7k 1.8× 5.4k 1.8× 1.1k 0.8× 1.3k 1.0× 907 0.7× 328 13.1k
Eugenii A. Rabiner 4.1k 0.8× 3.0k 1.0× 1.5k 1.1× 1.4k 1.1× 1.5k 1.2× 228 10.6k
Shuji Kaneko 4.0k 0.8× 3.8k 1.3× 1.0k 0.8× 1.9k 1.6× 1.1k 0.9× 361 10.5k
Giuseppe Di Giovanni 4.1k 0.8× 2.4k 0.8× 773 0.6× 936 0.8× 895 0.7× 193 7.6k
Chris G. Parsons 5.7k 1.2× 3.6k 1.2× 1.9k 1.4× 2.5k 2.0× 925 0.7× 146 9.3k

Countries citing papers authored by A.J. Cross

Since Specialization
Citations

This map shows the geographic impact of A.J. Cross's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A.J. Cross with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A.J. Cross more than expected).

Fields of papers citing papers by A.J. Cross

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A.J. Cross. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A.J. Cross. The network helps show where A.J. Cross may publish in the future.

Co-authorship network of co-authors of A.J. Cross

This figure shows the co-authorship network connecting the top 25 collaborators of A.J. Cross. A scholar is included among the top collaborators of A.J. Cross based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A.J. Cross. A.J. Cross is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jaffe, Andrew E., Richard E. Straub, Joo Heon Shin, et al.. (2018). Developmental and genetic regulation of the human cortex transcriptome illuminate schizophrenia pathogenesis. Nature Neuroscience. 21(8). 1117–1125. 211 indexed citations
2.
D’Souza, Manoranjan S., et al.. (2016). Attenuation of nicotine-taking and nicotine-seeking behavior by the mGlu2 receptor positive allosteric modulators AZD8418 and AZD8529 in rats. Psychopharmacology. 233(10). 1801–1814. 19 indexed citations
3.
Richards, Erica M., Daniel C. Mathews, David A. Luckenbaugh, et al.. (2016). A randomized, placebo-controlled pilot trial of the delta opioid receptor agonist AZD2327 in anxious depression. Psychopharmacology. 233(6). 1119–1130. 59 indexed citations
4.
Li, Ming, Andrew E. Jaffe, Richard E. Straub, et al.. (2016). A human-specific AS3MT isoform and BORCS7 are molecular risk factors in the 10q24.32 schizophrenia-associated locus. Nature Medicine. 22(6). 649–656. 108 indexed citations
5.
Augier, Eric, et al.. (2016). The mGluR2 Positive Allosteric Modulator, AZD8529, and Cue-Induced Relapse to Alcohol Seeking in Rats. Neuropsychopharmacology. 41(12). 2932–2940. 30 indexed citations
6.
Justinová, Zuzana, Leigh V. Panlilio, Maria E. Secci, et al.. (2015). The Novel Metabotropic Glutamate Receptor 2 Positive Allosteric Modulator, AZD8529, Decreases Nicotine Self-Administration and Relapse in Squirrel Monkeys. Biological Psychiatry. 78(7). 452–462. 47 indexed citations
7.
O’Sullivan, Joe M., Dag Clement Johannessen, Anders Widmark, et al.. (2013). Hematologic safety of radium-223 dichloride (Ra-223) in the phase 3 ALSYMPCA trial in castration-resistant prostate cancer (CRPC) patients with bone metastases : baseline prognostic factor subgroup analysis. European Journal of Cancer. 49. 3 indexed citations
8.
Shalhoub, Joseph, A.J. Cross, David Allin, et al.. (2011). Intra-plaque production of M1-type cytokines and matrix metalloproteinases differentiate stable from unstable carotid atherosclerosis. British journal of surgery. 98. 3–3. 2 indexed citations
9.
Hudzik, Thomas J., et al.. (2000). Disruption of acquisition and performance of operant response-duration differentiation by unilateral nigrostriatal lesions. Behavioural Brain Research. 114(1-2). 65–77. 11 indexed citations
10.
Cross, A.J., et al.. (1997). Neuroprotective agents and cerebral ischaemia. Academic Press eBooks. 56 indexed citations
11.
Shashkin, A. A., A. J. Kent, J. R. Owers-Bradley, et al.. (1997). Hall Photovoltage Imaging of the Edge of a Quantum Hall Device. Physical Review Letters. 79(25). 5114–5117. 26 indexed citations
12.
Tindberg, Niclas, Helen A. Baldwin, A.J. Cross, & Magnus Ingelman‐Sundberg. (1996). Induction of cytochrome P450 2E1 expression in rat and gerbil astrocytes by inflammatory factors and ischemic injury.. Molecular Pharmacology. 50(5). 1065–1072. 73 indexed citations
13.
Hu, Yingwei, C von Bahr, A.J. Cross, et al.. (1994). Chlormethiazole as an efficient inhibitor of cytochrome P450 2E1 expression in rat liver.. Journal of Pharmacology and Experimental Therapeutics. 269(3). 1286–1291. 67 indexed citations
14.
Bowen, David M., et al.. (1990). Spermidine enhancement of [3H]MK-801 binding to the NMDA receptor complex in human cortical membranes. European Journal of Pharmacology Molecular Pharmacology. 189(2-3). 195–200. 20 indexed citations
15.
Cross, A.J., et al.. (1989). The modulation by chlormethiazole of the GABAA‐receptor complex in rat brain. British Journal of Pharmacology. 98(1). 284–290. 65 indexed citations
16.
Blackburn, T.P., A.J. Cross, Christopher J. Hille, & P. Slater. (1988). Autoradiographic localization of delta opiate receptors in rat and human brain. Neuroscience. 27(2). 497–506. 42 indexed citations
17.
Simpson, M.D.C., A.J. Cross, P. Slater, & J.F.W. Deakin. (1988). Loss of cortical GABA uptake sites in Alzheimer's disease. Journal of Neural Transmission. 71(3). 219–226. 41 indexed citations
18.
Cross, A.J., Timothy J. Crow, Elaine K. Perry, et al.. (1981). Reduced dopamine-beta-hydroxylase activity in Alzheimer's disease. BMJ. 282(6258). 93–94. 211 indexed citations
19.
Cross, A.J., A. Longden, F. Owen, Mark Poulter, & John L. Waddington. (1978). Inter-relationships between behavioural and neurochemical indices of supersensitivity in dopaminergic neurones [proceedings].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 63(2). 383P–383P. 4 indexed citations
20.
Cross, A.J., et al.. (1978). Evidence for increased dopamine receptor sensitivity in post mortem brains from patients with schizophrenia [proceedings].. PubMed. 280. 37P–37P. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C. Anthony Altar Breakdown of academic impact, for papers by Anat Biegon Breakdown of academic impact, for papers by Stephen L. Dewey Breakdown of academic impact, for papers by Hayden T. Ravert Breakdown of academic impact, for papers by Paul L. Wood Breakdown of academic impact, for papers by Sven Ove Ögren Breakdown of academic impact, for papers by Eugenii A. Rabiner Breakdown of academic impact, for papers by Shuji Kaneko Breakdown of academic impact, for papers by Giuseppe Di Giovanni Breakdown of academic impact, for papers by Chris G. Parsons
Rankless by CCL
2026